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and epidemiological transition which gives rise to 
mortality rate more than 46%.[3]
In addition to risk factors for atherosclerosis including 
genetic factors, diet, and lifestyle, lipid profi le, and 
vascular infl ammatory responses are of importance.[4] 
Increased levels of triglyceride (TG) and low-density 
lipoprotein-cholesterol (LDL-C) are associated with 
CVD risk. On the other hand, the concentration of 
INTRODUCTION
Cardiovascular diseases (CVD), the leading cause of 
death in most countries,[1] are responsible for 35% of 
deaths in developing countries and 30% of death rate 
worldwide.[2] In Iran as in other developing countries, 
these diseases are increasing as a result of nutritional 
Background: Th is study investigated blackberry (Persian mulberry) eff ects on apo A-I, apo B, high-sensitivity-C-reactive protein 
(hs-CRP), and systolic blood pressure (SBP) and diastolic blood pressure (DBP) in dyslipidemic patients. Materials and Methods: 
In this 8-week randomized clinical trial, 72 dyslipidemic patients were randomly divided into two groups: Intervention (300 mL/day 
blackberry juice with pulp) and control group (usual diets). Before and after the intervention, fasting blood samples were taken from 
both groups and serum concentration of lipoprotein, apo A-I and apo B, serum lipids (total cholesterol, low-density lipoprotein, high-
density lipoprotein [HDL], and triglyceride), hs-CRP were measured. Blood pressure before and after the study was measured with 
a mercury manometer. Results: At week 8 in the intervention group, apo A-I and HDL increased signifi cantly (P = 0.015, P = 0.001, 
respectively), apo B and hs-CRP decreased signifi cantly (P = 0.044, P = 0.04, respectively). Mean changes in apo A-I and HDL and 
apo B/apo A-I ratio were signifi cant between the groups (P = 0.005, P = 0.014, and P = 0.009, respectively). After 8 weeks, there was a 
signifi cant diff erence between hs-CRP mean values (P = 0.01) of the groups. At week 8, SBP decreased signifi cantly (P = 0.005) in the 
intervention group with no signifi cant diff erences for SBP mean values between the groups. No signifi cant changes were observed in 
other lipid parameters and DBP in the intervention group and between the groups. Conclusion: Blackberry consumption may exert 
benefi cial eff ects on apolipoproteins, blood pressure, and infl ammatory markers in individuals with lipid disorders.
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high-density lipoprotein-cholesterol (HDL-C), independent 
of TG and LDL-C levels, is inversely associated with CVD 
risk.[5,6] Studies conducted in Iran show, the prevalence 
of lipid disorders, diabetes, hypertension, and obesity is 
increasing[7] which result from behavioral and nutritional 
characteristics and physical activity of Iranians.[8] Studies 
indicate that 10% reduction in serum total cholesterol 
(TC) reduces coronary heart disease (CHD) incidence to 
30%.[1] In this regard, in addition to medical treatments, 
the role of diet, fruits, and vegetables consumption has 
been demonstrated in controlling hyperlipidemia.[9] There 
is an increasing body of epidemiologic evidences showing 
the positive association between diets rich in fruits and 
vegetables and CHD risk decrease which can be aĴ ributed 
to both deactivating reactive oxygen species in the initiation 
and progression of chronic diseases by antioxidants and 
their phenolic contents.[10,11] Nonnutrient polyphenols 
such as fl avonoids exist in considerable amounts in fruits 
and vegetables that have powerful antioxidant eff ects on 
chemical systems. Both animal studies and clinical trials 
have shown benefi cial eff ects of polyphenol-rich foods 
on cardiovascular health.[12-14] Among them, berries are 
rich sources of fl avonoids (anthocyanins), some minerals 
(sodium, potassium, calcium, selenium, zinc, and 
phosphorus), Vitamins (A, B, C, and E), phenolic acids 
(gallic, P-coumaric, caffeic, and fluoric), and phenolic 
polymers (alajik acid).[15] Blackberry (Morus nigra L., 
Persian mulberry, and black mulberry), a native fruit to 
Iran, contains high levels of anthocyanins.[16] Interestingly, 
berries lack interfering compounds such as ethanol, fat 
and caff eine,[17] and their fl avonoids can be eff ective on 
cardiovascular health by several mechanisms. For instance, 
they may inhibit LDL-C oxidation, reduce infl ammation 
associated with atherosclerosis and also aff ect reverse 
cholesterol transport by reducing TC and LDL-C.[18] 
Evidences show adding berries to the diet can positively 
affect cardiovascular risk factors through inhibition 
of inflammation, free radical scavenging, regulating 
eicosanoid metabolism, improving endothelial function, 
reducing blood pressure, inhibition of platelet aggregation, 
increasing circulating HDL-C, and increasing resistance of 
LDL-C oxidation.[19] Studies on the eff ects of berries on lipid 
profi le and infl ammatory markers reveal contradictory 
results.[20-25] In some previous studies, signifi cant changes 
in lipid profile and some inflammatory markers have 
been observed whereas other studies did not report any 
signifi cant changes which may be contributed to limitations 
including lack of control group,[24] the form of consumed 
berries (capsules or powder),[25,26] and consuming the 
combination of diff erent berries,[27] berry consumption 
along with a special diet,[27] the small sample size, and 
short intervention period.[26] Therefore, according to the 
importance of antioxidant role of phenolic compounds in 
protection of many diseases, it seems that adding berries 
to diet can aff ect the heart diseases risk factors, such as 
lipid profi le, blood pressure, and infl ammatory markers.
Thus, in this study we hypothesised that blackberry 
consumption can improve apo A-I and B, high-sensitivity-
C-reactive protein (hs-CRP), and blood pressure in 
dyslipidemic patients in a larger sample size and a control 
group, to determine the eff ects of the blackberry itself, and 
in the form of the juice with pulp.
MATERIALS AND METHODS
Study population and design
This study was a randomized clinical trial evaluating the 
eff ects of blackberry consumption on serum apo A-I, apo 
B, hs-CRP, and blood pressure on dyslipidemic patients.
Of patients who referred to social security and Bu-Ali Sina 
clinics of Qazvin, 72 volunteers aged 25-65 years, were 
recruited with a diagnosis of hyperlipidemia[28] [Table 1]. 
Other inclusion criteria were: Body mass index = 20-35 
kg/m2, TC >200 mg/dL, and LDL-C >100 mg/dL. Exclusion 
criteria were: Taking drugs that aff ect lipid metabolism; 
smoking and alcohol consumption; pregnancy or lactation; 
systemic, chronic and infl ammatory diseases, liver, and 
kidney diseases; having allergy to berry families; and 
changes in diets and physical activities. At the beginning, 
the objectives of the study were described to participants in 
detail. It was emphasized that consumption of berries, had 
no adverse eff ects, and they could leave the study whenever 
they wanted. The present study was conducted according 
to consolidated standards of reporting trials guidelines[29] 
and it was approved by the Research Ethics CommiĴ ee of 
Tehran University of Medical Sciences (90/D/130/28/28) 
and was registered in Iranian registry of clinical trials 
(IRCT201205182365N7).
Treatment juices
Six-hundred kilograms of blackberry were purchased. 
AĞ erward, ready berry pulps were mixed with juice and 
were packed in boĴ les without preservatives or additives. 
To eliminate pathogens and increase shelf time, juices 
were pasteurized which all were done by the Avan Food 
Company. Prepared boĴ les were stored at +5°C. Every 
week, seven boĴ les were given to the participants in the 
Table 1: Characteristics of participants at baseline
Characteristics Blackberry 
group (n = 36)
Control 
group (n = 36)
P*
Age (year) 45.08±7.58 45.61±8.69 0.78
Weight (kg) 85.32±16.67 78.91±9.79 0.052
BMI (kg/m2) 29.20±4.45 28.02±3.27 0.2
Waist circumference (cm) 89.13±11.93 84.95±7.57 0.08
Values are mean ± SD and percentage; *P value (independent t-test); SD = Standard 
deviation; BMI = Body mass index
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intervention group, and they were asked to keep them 
in the fridge.
Study design
As participants were randomly divided into two groups 
of blackberry and control group using the table of random 
numbers, there was no confounding eff ect of sex (two 
groups of 36 people).
Individuals in the intervention group, took 300 mL of 
blackberry juice with pulp every day for 8 weeks, and the 
control group continued their usual diet with no berries. 
Participants were instructed to have half of the boĴ le in the 
morning (at 10:00 am) and the other half in the aĞ ernoon snack 
(5:00 pm) and refrain from eating berries with other meals and 
from ingesting them immediately aĞ er dairy products. Each 
week, participants were contacted to be sure of taking berries. 
Participants were asked to deliver full and empty boĴ les at 
the end of each week to calculate the compliance.
Data collection
Demographic characteristics of participants, including age, 
sex, medical history, type, and amount of medication were 
obtained by interviewing. Height was measured using the 
height gauge aĴ ached to the scale with accurately 0.5 cm 
without shoes and weight was measured by Seca scale 
with an accuracy of 100 g, in the fasting state and with light 
clothes and bare feet. Data of food intake including calorie, 
macronutrient, and micronutrient and daily servings of 
fruits and vegetables were obtained by 24 h food recall 
questionnaires at the beginning and at the end of the study 
and were analyzed by nutritionist.[4] Data of physical activity 
were collected using the international physical activity 
questionnaire at the beginning and at the end of the study. 
At weeks 0 and 8, fasting blood samples were taken from 
both groups to measure biochemical markers. Serum was 
isolated by centrifugation at 3000 rpm and stored at −70°C 
until the end of the study. TGs, TC, LDL-C, and HDL-C 
were measured by using colorimetric method (Pars Azmoon 
commercial kit, Iran). Serum hs-CRP was measured by ELISA 
(The Binding Site Group Ltd., UK). The concentration of apo 
A-I and apo B was determined by turbidimetric method (Pars 
Azmoon commercial kit, Iran). Systolic blood pressure (SBP) 
and diastolic blood pressure (DBP) were measured once, 
both at the beginning and at the end of the study, siĴ ing on 
chair and in nonstress conditions using a standard mercury 
sphygmomanometer. Fiber in the sample of blackberry was 
measured according to procedures of American Oil Chemists 
Society with the device of a single fi ber and polyphenols were 
measured by high-performance liquid chromatography.[26,30]
Measurement of total phenolic content of blackberry
Total phenolic content of blackberry extract was performed 
employing the literature methods involving Folin-Ciocalteu 
reagent and gallic acid as standard.[31] The extract samples 
(0.5 mL of diff erent dilutions) were mixed with 2.5 mL of 0.2 
N Folin-Ciocalteau reagent (Sigma-Aldrich) for 5 min and 
2.0 mL of 75 g/L sodium carbonate were then added. The 
mixture was allowed to stand for 2 h at room temperature. 
The absorbance was measured at 760 nm with a double 
beam PerkinElmer ultraviolet/visible spectrophotometer 
(USA). The standard curve was prepared using 50-250 mg/
mL solutions of gallic acid in methanol-water (1:1, v/v).
Total phenol values are expressed in terms of gallic acid 
equivalent (mg/g of dry mass) which is a common reference 
phenolic compound.
Statistical analysis
The data analyzed using SPSS 16 software (SPSS Inc., 
Chicago, IL, USA). Data were assessed for normality using 
Kolmogorov-Smirnov test. For variables with no normal 
distribution, nonparametric test (Wilcoxon test and Mann-
Whitney) was used. At weeks 0 and 8, quantitative variables 
were compared by independent t-test between the two 
groups. Paired t-test was used to compare the mean changes 
between pre- and post-intervention. Values are expressed 
as (mean ± standard deviation) and P < 0.05 was considered 
as statistically signifi cant.
RESULTS
According to the findings of the current study, the 
polyphenols were 316 mg and fi ber was 9.87 g/100 g of 
blackberry.
Of 72 participants, 54 (75%) were men and 18 (25%) 
were female. Demographic and clinical characteristics 
of participants at baseline show no signifi cant diff erence 
between the groups [Table 1].
Dietary intake and physical activity
No signifi cant diff erences were observed for physical 
activity (P = 0.55, data not shown) and dietary intakes 
between the groups before and aĞ er the study [Tables 2 
and 3].
Blood pressure
Blackberry consumption reduced mean SBP signifi cantly 
(P = 0.005) whereas this change was not signifi cant in the 
control group (P = 0.17). No signifi cant diff erence was 
observed in mean changes and mean values of SBP between 
the groups (P = 0.24 and P = 0.82, respectively) while aĞ er 
the intervention, there was not a signifi cant diff erence in 
mean changes and mean values of DBP between the groups 
(P = 0.63 and P = 0.98, respectively) and within the each 
group (respectively P = 0.3 [intervention group] and P = 0.13 
[control group]) [Table 4].
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Lipid profi le and high-sensitivity-C-reactive protein
As shown in Table 4, no signifi cant diff erence was observed 
in mean HDL-C between the groups at the end of the study 
(P = 0.91), however, comparison of mean changes between 
the groups revealed signifi cant diff erence (0.014), also the 
mean concentration of HDL-C levels in the intervention 
group had a signifi cant increase (0.001). However, we failed 
to fi nd a signifi cant change in other lipid parameters such as 
TC, LDL-C, and TG neither within nor between the groups 
[Table 4]. As shown in Table 5, blackberry consumption 
increased the mean value of apo A-I signifi cantly (P = 0.015) 
compared to the baseline. Despite the decrease of mean 
value of apo A-I in the control group, this reduction was 
not signifi cant (P = 0.11). However, the diff erences between 
the groups in mean changes of apo A-I was signifi cant 
(P = 0.005). Mean changes of apo B were not signifi cantly 
diff erent between the groups at the end of study whereas 
mean changes of apo B decreased significantly in the 
intervention group (P = 0.044), while no significant 
diff erences were observed in the control group (P = 0.07). 
The mean ratio of apo B to apo A-I in the intervention group 
was 0.76 ± 0.20 at baseline which declined to 0.69 ± 0.17 
at the end of the study and this decrease was statistically 
signifi cant (P = 0.001) but not in control group (P = 0.77). The 
statistical tests showed no signifi cant diff erences between 
the means of two groups at week 8 (P = 0.47) whereas the 
diff erences between the mean change of this ratio was 
signifi cant between the groups (P = 0.009).
This study showed a signifi cant reduction in mean value 
of hs-CRP in the intervention group (P = 0.04) and a 
nonsignifi cant reduction in the control group (P = 0.42). 
On the other hand, at the end of the study statistical tests 
showed a signifi cant diff erence for mean hs-CRP between 
the groups (P = 0.01) but we failed to fi nd a signifi cant 
diff erence in mean changes of this factor between the groups 
(P = 0.50) [Table 5].
DISCUSSION
Present study showed that consumption of blackberry juice 
with pulp for 8 weeks, gave a signifi cant rise to apo A-I 
and HDL-C and decreased the concentration of apo B, and 
hs-CRP. Mean changes of HDL-C, apo A-I, and apo B/apo 
A-I ratio were signifi cant between the groups. Signifi cant 
differences were observed for mean values of hs-CRP 
between the groups following blackberry intake. Besides, 
SBP decreased significantly in the intervention group 
compared to baseline aĞ er blackberry ingestion.
The fi nding of serum HDL-C in the present study was 
similar to previous studies.[21,24,27] However in contrast to our 
fi ndings, in a study by Lee et al. in 2008 in diabetic patients, 
there were no signifi cant changes in serum HDL-C aĞ er 
daily consumption of three 500 mg capsules of cranberry 
extract for 12 weeks.[32] In that study, the extract was in the 
form of capsules and was administrated for a long time 
(12 weeks) which reduced participant adherence to the 
intervention. In that study, since participants were diabetic 
and according to evidences, lipid abnormalities exist in 
diabetic patients,[33] this issue may disturb the results and 
prevent HDL-C from being aff ected. Similarly, in a study 
by Basu et al., no signifi cant changes were shown in HDL-C 
aĞ er taking 50 g of dried strawberries for 4 weeks[24] which 
may be due to the berries consumed in dried powder form or 
small size and short duration of the intervention compared 
to this study in which blackberries were consumed in 
juice form with pulp. Skoczyñska et al. did not detect any 
signifi cant changes in the HDL-C aĞ er consuming 250 mL/
day of chokeberry extract during a two 6-week period.[34] 
Polyphenols administered in that study were approximately 
1060 mg but in our study were 948 mg. Regarding equal 
amounts of polyphenols consumed in these two studies, we 
believe that HDL-C did not diff er because that experiment 
was conducted on healthy men with mild hyperlipidemia. 
According to the current study, 8-week consumption of 
blackberries did not have signifi cant eff ects on other lipid 
parameters including TC, LDL-C, and TG, which were 
in line with previous similar studies.[22-24,35-37] In contrast, 
Table 2: Energy and macronutrient intake in groups 
before and after of the intervention
Variables Intervention Blackberry 
group (n = 36)
Control group 
(n = 36)
P
Energy (kcal/
day)
Before 2714.4±436.86 2706.1±603.32 0.95
After 2653.1±474.98 2640.7±517.61 0.91
Differences −60.22±191.44 −65.4±231.9 0.91
P 0.063 0.099 —
Carbohydrates 
(g/day)
Before 397.50±66.92 388.56±83.70 0.61
After 387.72±67.64 380.34±70.79 0.65
Differences −9.77±37.57 −8.21±30.51 0.84
P 0.12 0.11 —
Protein (g/
day)
Before 100.84±15.76 101.98±21.10 0.79
After 98.22±15.84 96.76±18.39 0.71
Differences −2.61±8.37 −5.22±16.42 0.40
P 0.069 0.065 —
Fat (g/day) Before 87.42±18.18 87.77±24.59 0.94
After 83.60±23.91 85.04±26.42 0.80
Differences −3.81±18.81 −2.72±22.71 0.82
P 0.23 0.47 —
Cholesterol 
(mg/day)
Before 340.52±114.29 328.53±120.48 0.66
After 334.48±136.44 312.11±62.57 0.37
Differences −6.04±170.78 −1.64±101.31 0.75
P 0.83 0.33 —
Fiber (g/day) Before 7.30±1.96 8.99±10.07 0.32
After 6.82±2.09 7.28±2.27 0.38
Differences −0.48±2.77 −1.71±10.05 0.48
P 0.30 0.31 —
Values are mean ± SD; P value compare between the two groups (independent t-test); 
P value within groups (paired t-test). SD = Standard deviation
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in the study by Skoczyñska et al., daily intake of 250cc 
of chokeberry extract for two 6-week periods decreased 
serum TC and LDL-C, significantly[34] which supports 
the observations by Lee et al. in which LDL-C decreased 
significantly, and HDL-C did not change significantly 
following consumption of cranberry (three capsules of 500 
mg for 12 weeks), in diabetic patients.[32] These fi ndings 
could result from longer duration of treatments in both 
studies in contrast to our study. In Basu’s study in 2009, a 
reduction in TC and LDL-C and no changes in HDL-C, very 
low-density lipoprotein, and TG were reported following 
ingesting 50 g of dried strawberries for 4 weeks. This result 
may be explained by diff erent groups of women suff ered 
from metabolic syndrome, compared with our study.[25] In 
another study, supplementation with anthocyanins (two 
capsules of 80 mg for 12 weeks) reduced serum LDL-C 
whereas no changes in TC and TG were observed.[21] 
Anthocyanin consumed in that study was 160 mg, however, 
in our study it was equal to 948 mg of polyphenols thus, 
the reduction in LDL-C in contrast to our study, may result 
from a longer period of intervention. Also, in studies by 
Ruel et al., in 2006 and Burton-Freeman et al., in 2010 that 
were performed to evaluate the eff ects of cranberry and 
strawberry respectively, the only observed reduction was 
in serum concentration of TG.[20,38]
Further, there were a signifi cant increase in serum apo 
A-I and a signifi cant decrease of apo B concentration aĞ er 
consumption of blackberry compared to the baseline. 
In Ruel et al. study, increasing the dose of cranberry 
extract during 12 weeks (125, 250, and 500 mL) did not 
alter apo B although it increased apo A-I.[20] In contrast 
to our fi ndings, in a study by Qin et al. on the eff ects of 
anthocyanin supplementation in dyslipidemic people, daily 
consumption of two capsules of 80 mg anthocyanins for 12 
weeks did not aff ect apo A-I and apo B.[21] This issue could 
be as a result of lower contents of anthocyanin compared 
with our study which was 160 mg/day (two capsules of 80 
mg) versus intaking 948 mg/day polyphenols. Regarding 
the fact that apo B and apo A-I are the major apolipoproteins 
of LDL and HDL-C respectively, the reduction of apo B 
and increase of apo A-I in the intervention group, could be 
aĴ ributed to a nonsignifi cant reduction in serum LDL-C 
and a signifi cant increase in serum HDL-C.[1] By these two 
signifi cant changes, apo B/apo A-I, an important risk factor 
for CVD, was signifi cantly decreased in the intervention 
group. Another fi nding of this study was a signifi cant 
reduction in hs-CRP in the intervention group compared 
to control group and baseline. Contrary to our results, in 
the study by Skoczyñska et al., daily drinking of 250 mL 
chokeberry extract caused no signifi cant changes in CRP 
levels which may be due to the hyperlipidemia in subjects 
although they were healthy individuals.[34] In another study, 
3 weeks of taking two 500 mg capsules of cranberry did not 
alter CRP signifi cantly[32] which might be as a result of taking 
cranberries in capsule forms. Additionally, Basu et al. did not 
report a signifi cant change in concentration of hs-CRP aĞ er 4 
weeks of consuming 50 g of dried strawberries in 16 women 
with metabolic syndrome,[25] which a small sample size, 
short-term intervention, and lack of control group could 
aff ect the results. On the other hand, Lehtonen et al. in 2010 
and Udani et al. in 2011 failed to fi nd signifi cant changes in 
serum concentrations of CRP, interleukin, and adiponectin 
following the consumption of other types of berries.[28,37] 
This could be due to low dose of strawberries (163 g for 
20 weeks) or consuming a combination of berries in the fi rst 
study and the small sample size and short duration of the 
intervention (n = 10, 1-month) in the second one.
The beneficial effects observed can be attributed to 
phenolic compounds, anthocyanins, and other features 
Table 3: Mineral, micronutrient, fruit, and vegetable 
intake in groups before and after of the intervention
Variables Intervention Blackberry 
group (n = 36)
Control group 
(n = 36)
P
Vitamin A 
(RE/day)
Before 790.94±267.01 880.83±275.27 0.164
After 714.78±287.91 810.18±288.85 0.165
Differences −76.15±252.37 −70.64±264.31 0.94
P 0.07 0.25 —
Vitamin C 
(mg/day)
Before 142.66±51.04 149.72±51.11 0.56
After 131.36±41.04 160.03±42.44 0.05
Differences −11.29±54.23 10.31±58.62 0.10
P 0.22 0.29 —
Vitamin E 
(mg/day)
Before 11.93±7.75 14.06±8.64 0.27
After 11.34±6.90 14.42±9.19 0.11
Differences −0.59±8.47 0.36±8.68 0.63
P 0.67 0.80 —
Potassium 
(mg/day)
Before 3269±658 3371.6±668.05 0.51
After 3135±608.4 3186.1±611.44 0.72
Differences −134±596.01 −185.4±699.04 0.73
P 0.18 0.12 —
Magnesium 
(mg/day)
Before 3023±67.15 3104±70.03 0.61
After 2918.2±67.69 2986±72.62 0.68
Differences −10.47±60.95 −11.8±83.63 0.93
P 0.31 0.40 —
Selenium 
(mg/day)
Before 0.1301±0.033 0.119±0.032 0.17
After 0.1195±0.037 0.110±0.034 0.26
Differences −0.010±0.037 −0.0093±0.036 0.88
P 0.09 0.13 —
Fruit (units per 
day)
Before 2.02±0.89 2.03±0.70 0.95
After 1.89±0.71 1.89±0.69 0.97
Differences −0.12±0.61 −0.14±0.46 0.89
P 0.22 0.07 —
Vegetables 
(units per day)
Before 3.09±1.05 3.08±0.88 0.96
After 2.80±0.99 2.91±1.06 0.64
Differences −0.29±1.22 −0.16±1.08 0.65
P 0.16 0.35 —
Values are mean ± SD; P value compare between the two groups (independent t-test); 
P value within groups (paired t-test). SD = Standard deviation
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existing in blackberry.[39] Anthocyanins represent a wide 
range of biological activities including antioxidant, anti-
infl ammatory, antibacterial, and anticancer activities as 
well as, improving eyesight, induction of apoptosis and 
neuroprotection. Antioxidant activities of anthocyanins, 
(clearing free radicals, chelating metal-binding protein), 
including protecting LDL against oxidation, has been 
demonstrated in a number of diff erent experimental systems. 
It has been shown that pelargonidin, cyanidin, defi din, 
peonidin, and malvidin (common types of anthocyanins) 
have inhibitory eff ects on NO production in macrophages.[40] 
Accordingly, berry anthocyanins may play protective roles 
in the cardiovascular system through reducing oxidative 
stress and infl ammation, which is mediated by aff ecting 
NO activity, modifying dyslipidemia, and modulating the 
expression of eNO and thus maintaining normal vascular 
function and blood pressure.[41]
Current study revealed a signifi cant reduction in SBP aĞ er 
consumption of cranberry in the compared to baseline, while 
no signifi cant changes were observed in DBP although at the 
end of the study these parameters and their mean changes were 
not signifi cant between the groups. These results were similar 
to previous fi ndings.[27] In contrast, Skoczyñska et al.,[34] Basu 
et al.,[24] and also Lehtonen et al.,[37] revealed signifi cant reductions 
in both SBP and DBP. Unlike our study, the resulting changes 
in DBP in these studies could be aĴ ributed to the diff erences in 
the two studies’ groups as well as longer-term of intervention 
in the second study. However, contrary to these results, Jenkins 
et al. and Udani et al. did not detect any signifi cant changes in 
either SBP or DBP aĞ er taking 454 g of strawberry and 200 g, 
respectively of Acai berry for 1-month.[22,28] In both studies, 
treatment duration was 1-month, and it can be assumed that 
the lack of impact on blood pressure in these interventions was 
due to short-term of the interventions.
According to conducted studies and to our knowledge, this 
study is the fi rst study on the eff ects of blackberry fruit, 
native to Iran, on lipid profi le, apolipoproteins, hs-CRP, and 
blood pressure in patients with lipid disorders. A limitation 
of the present study was that it was not double blind and 
had no placebo.
CONCLUSION
Overall, this study showed that blackberry consumption 
has the potential to improve concentrations of HDL-C, 
apo A-I, apo B, and hs-CRP which in turn can modify the 
cardiovascular risk factors. Further research to investigate 
other inflammatory and oxidative stress markers with 
regard to longer duration and administrating diff erent doses 
of blackberry is recommended.
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